Menu Back toS42-Think-About-Informed-Consent-from-a-Patient-s-Perspective-What-Can-We-Do-to-Promote-Proper-Understanding-of-Clinical-Trials-and-PatientFriendly-Clinical-Trials
16th DIA Japan Annual Meeting 2019
[S42] Think About Informed Consent from a Patient’s Perspective – What Can We Do to Promote Proper Understanding of Clinical Trials and PatientFriendly Clinical Trials?
- Representative Director
- OnestepLung Cancer Patient Network ONE STEP, Japan
Informed consent is the first important process for patients to learn about and understand clinical trials. Recently, volume and complexity of Informed consent documents are increasing. In this session, we will discuss how we can improve informed consent documents and communication from a patient’s perspective based on the recent efforts in Japan and global.
Bringing Patient Centricity to Informed Consent and Promoting Understanding of Clinical Research Participation
David Leventhal, MBA
- Senior Director, Clinical Trial Experience
- Pfizer Inc, United States
How Do We Make “Easy-to-Understand ICF” Come True?
Yumiko Miyazaki, MSc
- Manager, Clinical Innovations & Business Integration,
- Eli Lilly Japan K.K., Japan
From the Standpoint of CRC That Uses Various ICFs and Supports Many Subjects
Yukari Suzuki, RN
- Chief Clinical Research Coordinator, Clinical and Translational Research Center
- Nigata University Medical and Dental Hospital, Japan
- Group Nexus Japan, Japan